# Elevance Health Earnings Boost But Margin Pressure Lingers

> Elevance Health raised 2026 EPS guidance to $29 but margin recovery remains uncertain.
- Title: Elevance Health Earnings Boost But Margin Pressure Lingers
- Summary: Elevance Health raised 2026 EPS guidance to $29 but margin recovery remains uncertain. Elevance Health increased 2026 adjusted EPS guidance to at least $29…
- Keywords: elevance health, 2026 eps, adjusted eps, margin pressure, medicaid, health benefits, capital returns, money, business, Elevance, Health, Earnings
- Source: Seekingalpha — https://seekingalpha.com/article/4956149-elevance-health-better-earnings-but-not-enough-to-buy
- Author: Motti Sapir
- Published: 2026-10-22T03:58:51+00:00
- Read time: 1 min
- Topics: elevance health, 2026 eps, adjusted eps, margin pressure, medicaid, health benefits, capital returns, money, business
## Elevance Health EPS Guidance
Elevance Health raised its 2026 adjusted EPS guidance to at least $29.
## Margin Pressure Continues
Third-quarter adjusted EPS rose 15.9% while nine-month operating gain declined 25.7%.
## Earnings Recovery Uncertain
Health Benefits margins remain under pressure particularly in Medicaid despite improving medical cost trends.
## Key takeaway

Elevance Health increased 2026 adjusted EPS guidance to at least $29 but margin pressure continues despite improving earnings.